Table 1 Baseline characteristics of patients in SA and EA group

Age, years (mean \(\pm\) SD)

41.6 \(\pm\) 10.8

39.1 \(\pm\) 10.8

0.389

Gender, n (%)

0.026*

 Female

12 (44.4%)

22 (73.3%)

 Male

15 (55.6%)

8 (26.7%)

Smoking, n (%)

3 (11.1%)

3 (10.0%)

0.891

Drinking, n (%)

5 (18.5%)

6 (20.0%)

0.888

Diabetes, n (%)

5 (18.5%)

9 (30.0%)

0.315

Hypertension, n (%)

9 (33.3%)

9 (30.0%)

0.787

Non-invasive Test

 Liver fat by MRI-PDFF, % [medium (p25, p75)]

20.8 (14.0, 28.1)

20.3 (13.8, 25.1)

0.371

 Liver stiffness by MRE, kPa (mean \(\pm\) SD)

2.4 \(\pm\) 0.7

2.6 \(\pm\) 0.9

0.519

Anthropometry parameters

 BMI, kg/m² (mean \(\pm\) SD)

31.8 \(\pm\) 4.9

33.0 \(\pm\) 4.1

0.342

 Body weight, Kg (mean \(\pm\) SD)

91.4 \(\pm\) 19.3

90.9 \(\pm\) 14.0

0.899

 WHR % (mean \(\pm\) SD)

92.8 \(\pm\) 6.7

92.5 \(\pm\) 5.6

0.870

Biochemical varieties

 ALT, U/L [medium (p25, p75)]

89.0 (81.5, 114.0)

95.5 (78.0, 121.0)

0.576

 AST, U/L [medium (p25, p75)]

50.5 (44.5, 66.0)

60.6 (48.9, 80.1)

0.099

 GGT, U/L [medium (p25, p75)]

67.0 (40.0, 78.0)

54.0 (37.8, 79.8)

0.533

 ALP, U/L (mean \(\pm\) SD)

92.8 \(\pm\) 27.5

89.8 \(\pm\) 23.8

0.659

 TC, mmol/L (mean \(\pm\) SD)

5.7 \(\pm\) 1.0

5.6 \(\pm\) 1.3

0.675

 TG, mmol/L [medium (p25, p75)]

1.8 (1.3, 2.2)

1.7 (1.4, 3.4)

0.743

 LDL-C, mmol/L (mean \(\pm\) SD)

3.5 \(\pm\) 0.7

3.3 \(\pm\) 0.7

0.296

 FBG, mmol/L (mean \(\pm\) SD)

5.9 \(\pm\) 1.1

6.1 \(\pm\) 1.2

0.522

 HbA1c % (mean \(\pm\) SD)

5.9 \(\pm\) 0.8

6.00 \(\pm\) 0.7

0.624

 HOMA-IR [medium (p25, p75)]

6.9 (4.3, 13.5)

9.3 (5.6, 13.7)

0.174